Dataset Information

Extent, causes, and consequences of small RNA expression variation in human adipose tissue.

ABSTRACT: Small RNAs are functional molecules that modulate mRNA transcripts and have been implicated in the aetiology of several common diseases. However, little is known about the extent of their variability within the human population. Here, we characterise the extent, causes, and effects of naturally occurring variation in expression and sequence of small RNAs from adipose tissue in relation to genotype, gene expression, and metabolic traits in the MuTHER reference cohort. We profiled the expression of 15 to 30 base pair RNA molecules in subcutaneous adipose tissue from 131 individuals using high-throughput sequencing, and quantified levels of 591 microRNAs and small nucleolar RNAs. We identified three genetic variants and three RNA editing events. Highly expressed small RNAs are more conserved within mammals than average, as are those with highly variable expression. We identified 14 genetic loci significantly associated with nearby small RNA expression levels, seven of which also regulate an mRNA transcript level in the same region. In addition, these loci are enriched for variants significant in genome-wide association studies for body mass index. Contrary to expectation, we found no evidence for negative correlation between expression level of a microRNA and its target mRNAs. Trunk fat mass, body mass index, and fasting insulin were associated with more than twenty small RNA expression levels each, while fasting glucose had no significant associations. This study highlights the similar genetic complexity and shared genetic control of small RNA and mRNA transcripts, and gives a quantitative picture of small RNA expression variation in the human population.

SUBMITTER: Parts L

PROVIDER: S-EPMC3349731 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Extent, causes, and consequences of small RNA expression variation in human adipose tissue.

Parts Leopold L Hedman Åsa K ÅK Keildson Sarah S Knights Andrew J AJ Abreu-Goodger Cei C van de Bunt Martijn M Guerra-Assunção José Afonso JA Bartonicek Nenad N van Dongen Stijn S Mägi Reedik R Nisbet James J Barrett Amy A Rantalainen Mattias M Nica Alexandra C AC Quail Michael A MA Small Kerrin S KS Glass Daniel D Enright Anton J AJ Winn John J Deloukas Panos P Dermitzakis Emmanouil T ET McCarthy Mark I MI Spector Timothy D TD Durbin Richard R Lindgren Cecilia M CM

PLoS genetics 20120510 5

Small RNAs are functional molecules that modulate mRNA transcripts and have been implicated in the aetiology of several common diseases. However, little is known about the extent of their variability within the human population. Here, we characterise the extent, causes, and effects of naturally occurring variation in expression and sequence of small RNAs from adipose tissue in relation to genotype, gene expression, and metabolic traits in the MuTHER reference cohort. We profiled the expression o ...[more]

PMID: 22589741

Similar Datasets

Project description:Ectonucleotide pyrophosphate phosphodiesterase (ENPP1) has been shown to negatively modulate insulin receptor and to induce cellular insulin resistance when overexpressed in various cell types. Systemic insulin resistance has also been observed when ENPP1 is overexpressed in multiple tissues of transgenic models and attributed largely to tissue insulin resistance induced in skeletal muscle and liver. Another key tissue in regulating glucose and lipid metabolism is adipose tissue (AT). Interestingly, obese patients with insulin resistance have been reported to have increased AT ENPP1 expression. However, the specific effects of ENPP1 in AT have not been studied. To better understand the specific role of AT ENPP1 on systemic metabolism, we have created a transgenic mouse model (C57/Bl6 background) with targeted overexpression of human ENPP1 in adipocytes, using aP2 promoter in the transgene construct (AdiposeENPP1-TG). Using either regular chow or pair-feeding protocol with 60% fat diet, we compared body fat content and distribution and insulin signaling in adipose, muscle, and liver tissues of AdiposeENPP1-TG and wild-type (WT) siblings. We also compared response to intraperitoneal glucose tolerance test (IPGTT) and insulin tolerance test (ITT). Our results show no changes in Adipose ENPP1-TG mice fed a regular chow diet. After high-fat diet with pair-feeding protocol, AdiposeENPP1-TG and WT mice had similar weights. However, AdiposeENPP1-TG mice developed fatty liver in association with changes in AT characterized by smaller adipocyte size and decreased phosphorylation of insulin receptor Tyr(1361) and Akt Ser(473). These changes in AT function and fat distribution were associated with systemic abnormalities of lipid and glucose metabolism, including increased plasma concentrations of fatty acid, triglyceride, plasma glucose, and insulin during IPGTT and decreased glucose suppression during ITT. Thus, our results show that, in the presence of a high-fat diet, ENPP1 overexpression in adipocytes induces fatty liver, hyperlipidemia, and dysglycemia, thus recapitulating key manifestations of the metabolic syndrome.

Project description:Animal movement comes in a variety of 'types' including small foraging movements, larger one-way dispersive movements, seasonally-predictable round-trip migratory movements, and erratic nomadic movements. Although most individuals move at some point throughout their lives, movement patterns can vary widely across individuals within the same species: differing within an individual over time (intra-individual), among individuals in the same population (inter-individual), or among populations (inter-population). Yet, studies of movement (theoretical and empirical alike) more often focus on understanding 'typical' movement patterns than understanding variation in movement. Here, I synthesize current knowledge of movement variation (drawing parallels across species and movement types), describing the causes (what factors contribute to individual variation), patterns (what movement variation looks like), consequences (why variation matters), maintenance (why variation persists), implications (for management and conservation), and finally gaps (what pieces we are currently missing). By synthesizing across scales of variation, I span across work on plasticity, personality, and geographic variation. Individual movement can be driven by factors that act at the individual, population, community and ecosystem level and have ramifications at each of these levels. Generally the consequences of movement are less well understood than the causes, in part because the effects of movement variation are often nested, with variation manifesting at the population level, which in turn affects communities and ecosystems. Understanding both cause and consequence is particularly important for predicting when variation begets variation in a positive feedback loop, versus when a negative feedback causes variation to be dampened successively. Finally, maintaining standing variation in movement may be important for facilitating species' ability to respond to future environmental change.

Project description:BackgroundAccumulation of visceral adipose tissue (VAT) is clearly associated with an increased risk of obesity-related diseases and all-cause mortality, whereas gluteal subcutaneous fat accumulation (g-SAT) is associated with a lower risk. The relative contribution, in term of cardiovascular risk, of abdominal subcutaneous adipose tissue (a-SAT) is still controversial with studies showing both a detrimental effect and a protective role. Animal and in vitro studies demonstrated that adipocytes from visceral and subcutaneous depots have distinct morphological, metabolic and functional characteristics. These regional differences have a key role in the pathogenesis of obesity-related diseases. There is recent evidence that differentiation between upper-body and lower-body adipose tissues might be under control of site-specific sets of developmental genes, such as Homebox (HOX) genes, a group of related genes that control the body plan of an embryo along the anterior-posterior axis. However, the possible heterogeneity between different subcutaneous regions has not been extensively investigated. Here we studied global mRNA expression in g-SAT and a-SAT with a microarray approach. RNA was isolated from g-SAT and a-SAT biopsy, from eight healthy subjects, and hybridized on RNA microarray chips in order to detect regional differences in gene expression.ResultsA total of 131 genes are significantly and differently (>1.5 fold change, p < 0.05) expressed in a-SAT and g-SAT. Expression profiling reveals significant differences in expression of several HOX genes. Interestingly, two molecular signature of visceral adipocyte lineage, homebox genes HOXA5 and NR2F1, are up-regulated in a-SAT versus g-SAT by a 2.5 fold change.ConclusionsOur study shows that g-SAT and a-SAT have distinct expression profiles. The finding of a different expression of HOX genes, fundamental during the embryo development, suggests an early regional differentiation of subcutaneous adipose depots. Moreover, the higher expression of HOXA5 and NR2F1, two molecular signatures of visceral adipocytes, in a-SAT suggests that this subcutaneous adipose depot could be more similar to VAT than g-SAT. Our data suggest that we should look at SAT as composed of distinct depots with possibly different impact in obesity associated metabolic complications.

Dataset Information

Extent, causes, and consequences of small RNA expression variation in human adipose tissue.

Publications

Extent, causes, and consequences of small RNA expression variation in human adipose tissue.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets